Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

HER2-positive Breast Cancer 1

Interventions

pembrolizumab 550 Specimen Handling 462 Carboplatin 441 Magnetic Resonance Spectroscopy 429 Cyclophosphamide 412 Cisplatin 398 Radiotherapy 313 Gemcitabine 310 Bevacizumab 306 Paclitaxel 294 Biopsy 259 Drug Therapy 248 Capecitabine 241 Oxaliplatin 239 fludarabine 238 Nivolumab 224 venetoclax 219 Injections 213 Docetaxel 205 Fluorouracil 202 Dexamethasone 186 Radiosurgery 172 Rituximab 158 Pemetrexed 153 Standard of Care 145 durvalumab 143 Leucovorin 138 atezolizumab 137 toripalimab 134 tislelizumab 134

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × Isovaleryl-CoA Dehydrogenase × Clear all

NCT07281001 2025-12-15

Traderrus

Blokhin's Russian Cancer Research Center

Phase NA Recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡